Lowey Dannenberg P.C. is investigating Alignment Healthcare, Inc. for potential violations of federal securities laws. The investigation follows a July 8, 2026 whistleblower lawsuit by a former chief transformation officer alleging the company misclassified $8 million to $10 million in routine operating expenses as capital expenditures to artificially inflate adjusted EBITDA and report its first full year of positive adjusted EBITDA as a public company. Alignment Healthcare stock fell $4.02 per share, or approximately 16.7%, to close at $20.03 per share on July 8, 2026. The law firm is examining whether the company and its executives provided accurate and complete information to investors.
Alignment Healthcare LLCInvestigation into alleged securities law violations and accounting misclassification.
